Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

459 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and immunogenicity of the malaria vaccine candidate MSP3 long synthetic peptide in 12-24 months-old Burkinabe children.
Sirima SB, Tiono AB, Ouédraogo A, Diarra A, Ouédraogo AL, Yaro JB, Ouédraogo E, Gansané A, Bougouma EC, Konaté AT, Kaboré Y, Traoré A, Chilengi R, Soulama I, Luty AJ, Druilhe P, Cousens S, Nébié I. Sirima SB, et al. Among authors: ouedraogo e, ouedraogo al, ouedraogo a. PLoS One. 2009 Oct 26;4(10):e7549. doi: 10.1371/journal.pone.0007549. PLoS One. 2009. PMID: 19855847 Free PMC article. Clinical Trial.
FcγRIIa polymorphism and anti-malaria-specific IgG and IgG subclass responses in populations differing in susceptibility to malaria in Burkina Faso.
Cherif MK, Sanou GS, Maiga B, Israelsson E, Ouédraogo AL, Bougouma EC, Diarra A, Ouédraogo A, Ouattara AS, Troye-Blomberg M, Dolo A, Cavanagh DR, Theisen M, Modiano D, Sirima SB, Nebié I. Cherif MK, et al. Among authors: ouedraogo al, ouedraogo a. Scand J Immunol. 2012 Jun;75(6):606-13. doi: 10.1111/j.1365-3083.2012.02690.x. Scand J Immunol. 2012. PMID: 22268665 Free article.
Haematological parameters, natural regulatory CD4 + CD25 + FOXP3+ T cells and γδ T cells among two sympatric ethnic groups having different susceptibility to malaria in Burkina Faso.
Sanou GS, Tiendrebeogo RW, Ouédraogo AL, Diarra A, Ouédraogo A, Yaro JB, Ouédraogo E, Verra F, Behr C, Troye-Blomberg M, Modiano D, Dolo A, Torcia MG, Traoré Y, Sirima SB, Nébié I. Sanou GS, et al. Among authors: ouedraogo e, ouedraogo al, ouedraogo a. BMC Res Notes. 2012 Jan 27;5:76. doi: 10.1186/1756-0500-5-76. BMC Res Notes. 2012. PMID: 22283984 Free PMC article.
Efficacy and safety of the mosquitocidal drug ivermectin to prevent malaria transmission after treatment: a double-blind, randomized, clinical trial.
Ouédraogo AL, Bastiaens GJ, Tiono AB, Guelbéogo WM, Kobylinski KC, Ouédraogo A, Barry A, Bougouma EC, Nebie I, Ouattara MS, Lanke KH, Fleckenstein L, Sauerwein RW, Slater HC, Churcher TS, Sirima SB, Drakeley C, Bousema T. Ouédraogo AL, et al. Among authors: ouedraogo a. Clin Infect Dis. 2015 Feb 1;60(3):357-65. doi: 10.1093/cid/ciu797. Epub 2014 Nov 19. Clin Infect Dis. 2015. PMID: 25414262 Clinical Trial.
459 results